COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 171 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,718,179 | +4.8% | 76,876 | +0.8% | 0.01% | 0.0% |
| Q2 2023 | $1,639,494 | -4.1% | 76,291 | +7.0% | 0.01% | -12.5% |
| Q1 2023 | $1,709,719 | -20.9% | 71,268 | -23.5% | 0.01% | -20.0% |
| Q4 2022 | $2,161,567 | -2.9% | 93,171 | -33.0% | 0.01% | -16.7% |
| Q3 2022 | $2,227,000 | +2.2% | 139,018 | +13.1% | 0.01% | +9.1% |
| Q2 2022 | $2,178,000 | +7.5% | 122,898 | +23.5% | 0.01% | +37.5% |
| Q1 2022 | $2,026,000 | +291.9% | 99,519 | +355.0% | 0.01% | +300.0% |
| Q2 2021 | $517,000 | -5.5% | 21,871 | -5.2% | 0.00% | 0.0% |
| Q1 2021 | $547,000 | -36.4% | 23,071 | -46.2% | 0.00% | -50.0% |
| Q4 2020 | $860,000 | -7.2% | 42,921 | -3.6% | 0.00% | 0.0% |
| Q3 2020 | $927,000 | +16.5% | 44,516 | -2.1% | 0.00% | 0.0% |
| Q2 2020 | $796,000 | +30.5% | 45,476 | +21.7% | 0.00% | 0.0% |
| Q1 2020 | $610,000 | +58.9% | 37,360 | +132.0% | 0.00% | +100.0% |
| Q2 2018 | $384,000 | – | 16,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tejara Capital Ltd | 289,803 | $6,477,097 | 3.67% |
| Tamarack Advisers, LP | 185,000 | $4,134,750 | 2.68% |
| Rubric Capital Management LP | 3,175,000 | $70,961,250 | 2.66% |
| Eventide Asset Management | 2,631,334 | $58,810,315 | 1.06% |
| Camber Capital Management LP | 1,050,000 | $23,468 | 0.77% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 559,480 | $12,504,378 | 0.76% |
| EMERALD ADVISERS, LLC | 690,487 | $15,432,380 | 0.75% |
| Values First Advisors, Inc. | 43,507 | $972,374 | 0.63% |
| AlphaCentric Advisors LLC | 49,500 | $1,106,325 | 0.63% |
| SummerHaven Investment Management, LLC | 33,666 | $752,435 | 0.55% |